Xhignesse P, 2018
KLASIFIKASI
Aliran Darah
Tekanan Perfusi turun
Turun
Resistensi Pembuluh Darah
meningkat
Vasokontriksi
Ischemia
Kerusakan Organ
Terapi
Farmakologi
Sharma Chanderdeep, et. al. “Hydralazine vs nifedipine for acute hypertensive emergency in pregnancy: a
randomized controlled trial” dengan membandingkan efek hidralazin injeksi (5 mg, 10 mg, 10 mg, 10 mg) dan
nifedipin oral 10 mg (dosis tetap) pada wanita hamil 24 minggu atau lebih dengan tekanan darah sistolik ≥160
mmHg atau tekanan darah diastolik ≥ 110 mmHg, menunjukkan efikasi yang sama dalam menurunkan tekanan
darah pada hipertensi emergensi akut pada kehamilan (P = 0,809)
Malik Mohammad Azharuddin, et. al. “A comparative study of intravenous labetalol VS intravenous nitroglycerin in
the treatment of hypertensive crises” membandingkan efek labetolol dan nitrogliserin iv dalam menurunkan tekanan
darah. Dihasilkan labetolol iv menurunkan tekanan darah lebih cepat yang terlihat pada menit ke-30 berlanjut hingga
2 jam (P < 0,05) berbeda secara signifikan dibandingkan nitrogloserin iv, dengan persentase jumlah pasien yang
mencapai target tekanan darah dalam 1 jam 96 % pada kelompok labetolol iv dan 44 % untuk nitrogliserin iv.
PUSTAKA
• Bahalura, A.M., Moroi, S.L., Udriste, A.S., Weiss, E., Japie, C., Bartos, D. and Badila, E 2022, ‘’The Management of Hypertensive
Emergencies-Is There a “Magical” Prescription for All?’’, MDPI, Volume 11, https://doi.org/ 10.3390/jcm11113138
• Cheng, W. L. (2019). Interpretation of the 2018 ESC/ESH Guidelines for the Management of Arterial Hypertension. In Chinese General
Practice (Vol. 22, Issue 21). https://doi.org/10.12114/j.issn.1007-9572.2019.00.224
• Malik Mohammad Azharuddin, et. al. 2022, “A comparative study of intravenous labetalol VS intravenous nitroglycerin in the
treatment of hypertensive crises”, Indian Heart Journal
• Mancia, G., Fagard, R., Narkiewicz, K., Redon, J., Zanchetti, A., Böhm, M., Christiaens, T., Cifkova, R., De Backer, G., Dominiczak,
A., Galderisi, M., Grobbee, D. E., Jaarsma, T., Kirchhof, P., Kjeldsen, S. E., Laurent, S., Manolis, A. J., Nilsson, P. M., Ruilope, L. M.,
… Wood, D. A. (2013). 2013 ESH/ESC guidelines for the management of arterial hypertension: The Task Force for the management of
arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). European
Heart Journal, 34(28), 2159–2219. https://doi.org/10.1093/eurheartj/eht151
• Park Sung Keun, et. al., 2017, “Comparing the clinical efficacy of resting and antihypertensive medication in patients of hypertensive
urgency: a randomized, control trial”, Journal of Hypertension.
• Perhimpunan Dokter Hipertensi Indonesia (PERHI). (2019). Konsensus Penatalaksanaan Hipertensi 2019. Indonesian Society
Hipertensi Indonesia, 1–90.
• Sharma Chanderdeep, et. al., 2017, “Hydralazine vs nifedipine for acute hypertensive emergency in pregnancy: a randomized
controlled trial”, merican Journal of Obstetrics & Gynecology
• Varounis et al. 2016. Cardiovascular Hypertensive Crisis: Recent Evidence and Review of the Literature. Frontiers in Cardiovascular
Medicine
PUSTAKA
• Whelton, P. K., Carey, R. M., Mancia, G., Kreutz, R., Bundy, J. D., & Williams, B. (2022). Harmonization of the American College
of Cardiology/American Heart Association and European Society of Cardiology/European Society of Hypertension Blood
Pressure/Hypertension Guidelines: Comparisons, Reflections, and Recommendations. Circulation, 146(11), 868–877.
https://doi.org/10.1161/CIRCULATIONAHA.121.054602
• Xhignesse P, Krzesinski F, Krzesinski JM. Les crises hypertensives [Hypertensive crisis]. Rev Med Liege. 2018 May;73(5-
6):326-332. French. PMID: 29926574.
• Zeind, C.S and Carvalho, M.G 2018. ‘’Applied Therapeutics The Clinical Use of Drugs 11th Edition’’. Philadelphia: Wolters Kluwer.